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Intrahippocampal administration of kainic acid (KA) induces synaptic release of neurotrophins, mainly brain-derived neu-
rotrophic factor, which contributes to the acute neuronal excitation produced by the toxin. Two protein tyrosine kinase inhibitors,
herbimycin A and K252a, were administered intracerebroventricularly, in a single dose, to attenuate neurotrophin signaling
during the acute effects of KA, and their role in epileptogenesis was evaluated in adult, male Wistar rats weighing 250-300 g. The
latency for the first Racine stage V seizure was 90 ± 8 min in saline controls (N = 4) which increased to 369 ± 71 and 322 ± 63
min in animals receiving herbimycin A (1.74 nmol, N = 4) and K252a (10 pmol, N = 4), respectively. Behavioral alterations were
accompanied by diminished duration of EEG paroxysms in herbimycin A- and K252a-treated animals. Notwithstanding the
reduction in seizure severity, cell death (60-90% of cell loss in KA-treated animals) in limbic regions was unchanged by
herbimycin A and K252a. However, aberrant mossy fiber sprouting was significantly reduced in the ipsilateral dorsal
hippocampus of K252a-treated animals. In this model of temporal lobe epilepsy, both protein kinase inhibitors diminished the
acute epileptic activity triggered by KA and the ensuing morphological alterations in the dentate gyrus without diminishing cell
loss. Our current data indicating that K252a, but not herbimycin, has an influence over KA-induced mossy fiber sprouting further
suggest that protein tyrosine kinase receptors are not the only factors which control this plasticity. Further experiments are
necessary to elucidate the exact signaling systems associated with this K252a effect.
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Introduction
Kainate binding sites have been described in the hip-
pocampus as being restricted to the molecular layer of
granule cells and to the stratum lucidum of the CA3 region,
where the mossy fibers (granule cell axons) terminate (1).
In vivo, intracerebral injection of kainic acid (KA) leads to
selective destruction of pyramidal CA3 neurons (2) and are
associated with epileptiform discharges (3). KA adminis-
tration also mimics some features of human temporal lobe
epilepsy (4), i.e., hippocampal neuronal loss, reactive glio-
sis, mossy fiber sprouting (MFS), and spontaneous recur-
rent seizures (5).
Intrahippocampal injection of KA increases brain-de-
rived neurotrophic factor (BDNF) immunoreactivity in the
mossy fiber terminal zone (6) and it is postulated that
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BDNF protein production could be related to the long-term
effects of KA (7). In fact, in vitro blockade of the tyrosine
kinase receptor TrkB signaling inhibits mossy fiber forma-
tion (8), which in turn is strongly induced by local applica-
tion of its endogenous ligand, the BDNF molecule (9).
Recently, it was demonstrated that K252a, an inhibitor of
tyrosine kinase activities, delayed KA-induced murine gran-
ule cell dispersion and increased MFS without modifying
perforant path evoked granule cell responses (10).
In the present study, we investigated the effects of two
different protein tyrosine kinase inhibitors, K252a and her-
bimycin A, on the acute epileptiform activity, cell death and
MFS induced by the intrahippocampal injection of KA in
rats. We hypothesized that blockade of protein tyrosine
phosphorylation could attenuate the epileptiform discharges
in the hippocampus and, thus, reduce the associated
morphological alterations in the hippocampus (as indi-
cated by cell death and MFS).
Material and Methods
Stereotaxic surgery
Male Wistar rats weighing 250-300 g were positioned
in a stereotaxic frame (David Kopf, USA) under halothane
anesthesia (4% induction and 1% maintenance). After
exposure of the skull, small holes were drilled above the
target structure according to the bregma and a stereotaxic
atlas (11). Using a silica needle (∅ = 1 mm) attached to a
Hamilton syringe, KA (0.2 µL of 1 µM) or saline were slowly
administered (0.2 µL/min) into the right dorsal hippocam-
pus (intrahippocampal administration), over the hilar-CA3
border region (-3.4, -2.5, and -3.5 mm). A 5-µL Hamilton
syringe, attached to another silica needle, was used for the
intracerebroventricular (icv ; -0.8, -1.5, -2.9 mm) adminis-
tration of 5 µL (2 µL/min) herbimycin A (348 µM), K252a (2
µM) or vehicle (1% dimethylsulfoxide, DMSO). In all cases,
after injection the needle was allowed to rest for 2 min to
allow the adequate distribution of the solution through the
structure. Thereafter, bipolar electrodes were implanted in
both dorsal hippocampi (-3.6, ±3.5, -3.5 mm) and fixed with
dental cement to a plastic plug (Plastics One, USA). The
time between the intrahippocampal and the icv administra-
tions was approximately 20 min and the total time of
surgery was never greater than 90 min. Using this proce-
dure, the rats were divided into 4 groups (intrahippocampal
and icv administrations, respectively): saline and DMSO
(SAL-DMSO; N = 5); KA and DMSO (KA-DMSO; N = 4); KA
and herbimycin A (KA-HERB; N = 4); KA and K252a (KA-
K252a; N = 4). The post-surgery condition of the animals
was monitored carefully during the following days. Animals
were manipulated in accordance with ethical guidelines
and the experimental procedures were previously approved
by the Ethics Research Committee of UNIFESP/EPM
(CEP1078/00).
EEG recording
Immediately after the surgery, the animals were con-
nected through a cable to a digital EEG system (Harmony,
Nicolet, USA). The signal was amplified, sampled at 250
Hz and filtered under 0.1 and above 100 Hz. The record-
ings started 1 h after drug administration and were regis-
tered continuously for 4 h. Subsequently, the recordings
were made for 2 min every 20 min during the following 72
h. The recordings were analyzed qualitatively off-line for
the onset and duration of the epileptiform activity in both
hippocampi. ANOVA followed by the post hoc Student-
Newman-Keuls test was used for comparison of seizure-
like latencies.
Histology: Nissl and neo-Timm
After 45 days (chronic phase), animals were anesthe-
tized profoundly (thiopental, 40 mg/kg) and transcardially
perfused for the neo-Timm staining as described previ-
ously (12). Brains were sectioned on a cryostat and 40-µm
thick coronal slices were mounted on glass slides for
processing. The slides were immersed in a 360-mL solu-
tion (21°C) containing 240 mL gum arabic, 10.25 g citric
acid, 9.45 g sodium citrate, 3.73 g hydroquinone, and 510
mg silver nitrate for approximately 45 min for neo-Timm
staining. Visual inspections of the slides were used to
control the reaction time. Adjacent sections were used to
assess cell death using Nissl staining (0.4% cresyl-violet)
and electrode placement.
Cell counting and dentate gyrus width measurements
Cell counting was performed on Nissl-stained sections
as described elsewhere (13). Briefly, cell body nuclei (∅
≈10 µm, for hilar cells and ∅ ≈7 µm for cortical cells) were
counted in ipsi- and contralateral hilar regions at 400X
magnification over a 4 x 4 (10,000 µm2) microscope grid
(Olympus BX50, USA) based on the rat stereotaxic atlas
(11). The hilar region was defined by the granule cell layer
borders and by two imaginary lines drawn from the apex of
the dentate gyrus and the proximal end of the CA3 pyrami-
dal cell layer. Counting was carried out in four different
portions of the hilar region in three different slices of the
dorsal hippocampus separated by 200 µm. Since the total
area evaluated for each hilus/animal was the same, mean
counting for each group was normalized based on the
control group counting (SAL-DMSO = 1). Thus, cell density
was reported as median and interquartile intervals. Gran-
ule cell dispersion was evaluated by the width of a line
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perpendicular to the cell layer in the suprapyramidal region
of the dentate gyrus at two levels: the apex and the knee.
Although both measurements (cell counts and dentate
dispersion) do not allow comparisons with reports of other
studies, they are sufficient to show differences between
treatments and hemispheres, in addition to being less
time-consuming. The Kruskal-Wallis test followed by the
Mann-Whitney U-test was used to compare cell density
and ANOVA followed by the post hoc Student-Newman-




Animals from all groups recovered from the anesthesia
4-6 min following discontinuation of 1% halothane ventila-
tion. While animals from the SAL-DMSO group walked,
groomed and slept after surgery, animals injected with KA
presented tremors, clonic movements, wild-running, Racine
stage V seizure (14), and status epilepticus (KA-DMSO: 3
of 4 animals; KA-HERB: 3 of 4 animals; KA-K252a: 2 of 4
animals). Notwithstanding the similar behavioral evolution
between groups that received KA, animals in the KA-
DMSO group presented their first Racine stage V seizure
90 ± 8 min after KA administration, while this latency was
369 ± 71 and 322 ± 63 min for KA-HERB and KA-K252a,
respectively (P < 0.05; KA-DMSO vs KA-HERB or KA-
K252a). Spontaneous seizures were rarely observed in
the days after KA injection (only animals of the KA-DMSO
group (2 of 4) presented spontaneous seizures), although
it should be noted that no systematic attempt was made to
address this issue.
EEG profile
Although the recordings were initiated just after elec-
trode implantation, animals from the control group dis-
played a normal EEG, i.e., steady interictal spikes or
epileptiform activity was never recorded in these animals.
KA administration produced isolated interictal spikes, sus-
tained synchronous activity and epileptiform discharges
(Figure 1; KA-DMSO). Herbimycin or K252a co-treatment
did not completely inhibit the epileptiform discharge but
changed the temporal profile of this activity. Herbimycin
co-treatment delayed and inhibited the spreading of the
epileptic activity to the contralateral hippocampus in all
animals, clearly in contrast with the pattern of seizure
spread that occurred in all animals of the KA-DMSO group
(Figure 1). The duration of the ipsilateral hippocampal
seizure in animals co-treated with herbimycin was shorter
than in the KA-DMSO group. K252a co-treatment also
changed the epileptiform profile, but in a different manner.
K252a was not able to inhibit the spread of seizure activity
to the contralateral side but shortened the seizure dis-
charges to less than 1 min each (Figure 1). These shorter
seizure activity epochs persisted during the first 4 h of the
recordings. Thus, while KA-DMSO animals showed a con-
tinuous epileptiform activity also in the hippocampus con-
tralateral to the KA-injected site, KA-K252a animals dis-
played intermittent epileptiform activity in the same brain
hemisphere.
Cell death and granule cell dispersion
KA treatment produced massive death of hilar cells and
pyramidal CA3 neurons ipsilateral to the KA injection site
(Figure 2D,E). Despite an apparent preservation of CA1
pyramidal neurons, the gross architecture of this layer and
Figure 1. Representative EEG recordings of the first epileptiform activity after intrahippocampal administration of kainic acid (KA; 0.2
µL of 1 µM) to a rat. Intracerebroventricular administration (20 min later) of herbimycin (HERB; 5 µL of 348 µM) modified KA-induced
hippocampal synchronization and its spread to the contralateral hippocampus, while K252a (5 µL of 2 µM) administration reduced the
duration of the epileptiform activity and modified its pattern. HPC-R = right hippocampus (site of KA injection); HPC-L = left
hippocampus (contralateral side); DMSO = 1% dimethylsulfoxide. Calibration bar: 500 µV and 1 s.
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Figure 2. Representative photomicro-
graphs of Nissl-stained sections of hippo-
campal structures, ipsilateral to site of
kainic acid (KA) administration in rats. KA-
treated animals displayed extensive cell
loss in the CA3 region (asterisks in E, H,
and K). Protein tyrosine kinase inhibitors
(1.74 nmol herbimycin or 10 pmol K252a)
administered icv were not able to protect
against cell death (compared with the
SAL-DMSO group, B). Hilar cells were ob-
served in the control group (A, arrow-
heads), but were absent after KA treat-
ment (D, G, J). Mild alterations were ob-
served in the CA1 region after KA treat-
ment (F, I, L), compared to the SAL-
DMSO group (C). mol = molecular layer of
dentate gyrus; GC = granule cell layer; h =
hilar region; rad = stratum radiatum; Pyr =
stratum pyramidale; ori = stratum oriens.
See legend of Figure 1 for experimental
details.
Figure 3. Cell survival 45 days after intra-
hippocampal kainic acid (KA) administra-
tion to rats. KA treatment produced clear
hilar cell death in the ipsilateral (right, B)
hilus, while the contralateral (left, A) cells
were preserved. Herbimycin (HERB, 1.74
nmol) and 10 pmol K252a icv treatment
did not attenuate KA-induced cell death.
Data are reported as median and inter-
quartile intervals for N = 4 rats in each
group except for SAL-DMSO in which N =
5. *P < 0.05 compared to SAL-DMSO
group. See legend of Figure 1 for experi-
mental details.
of the cellular morphology was altered by KA treatment
(Figure 2F). Extensive cell death was observed and quan-
tified in the ipsilateral dorsal hilus (P < 0.01, Figure 3B).
Nissl cell counting revealed no differences between the
various KA-treated groups (DMSO, K252a or herbimycin),
that ranged from 60-90% reduction in the cell counts. KA
treatment also led to mild granule cell dispersion (Figure
2D,G,J). There was a trend in KA-treated groups to present
an increased width of the suprapyramidal granule cell
layer in the knee (~20%, Figure 4A) and a decreased width
in the apex regions (~10%, Figure 4B) in the ipsilateral
hippocampus; although, there were no distinguishable
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Figure 4. Granule cell dispersion 45 days after intrahippocampal
kainic acid (KA) treatment of rats. The knee (A) portion of the
granule cell layer was thinner than the apex (B) portion (note that
the difference in scale used is almost 1.5-fold on the y-axis).
Herbimycin (HERB, 1.74 nmol) and 10 pmol K252a icv adminis-
tration did not modify granule cell layer width. Data are reported
as means ± SEM for N = 4 rats in each group except for SAL-
DMSO in which N = 5. See legend of Figure 1 for experimental
details.
Figure 5. Representative photomicrographs of neo-Timm stain-
ing from the apex of dentate gyrus (DG). Arrowheads show the
branches in the intragranular layer and arrows show silver grains
in the inner molecular layer. Note that kainic acid (KA) treatment
reduced intragranular staining and increased inner molecular
layer staining. This morphological alteration was more intense in
the ipsilateral DG. Herbimycin (HERB, 1.74 nmol, icv) attenuated
staining in the inner molecular layer while 10 pmol K252a icv
almost abolished the aberrant mossy fiber sprouting. See legend
of Figure 1 for experimental details.
differences between granule cell layer width in either hemi-
sphere for all groups analyzed (data not shown). There
were also no alterations in cell counts in the contralateral
hilar region (Figure 3A) as well as in the CA3 and CA1
regions (data not shown).
Mossy fiber sprouting
In control animals, neo-Timm staining was seen in the
hilus and stratum lucidum of CA3 regions. Intragranular
mossy fibers were observed in both hemispheres of the
control group, mainly at the apex of the dentate gyrus
(Figure 5; SAL-DMSO). These consisted of small branches
emerging from granule cells towards the inner molecular
layer of the dentate gyrus. KA treatment led to the appear-
ance of small silver grains in the inner molecular layer of
the dentate gyrus, mainly ipsilateral to the KA injection site
(Figure 5; KA-DMSO and KA-HERB). These grains were
observed in the apex and in the crests of the dentate gyrus.
KA-K252a-treated animals presented less pronounced su-
pragranular MFS in both hemispheres with a similar extent
of intragranular fibers. The amount of silver grains in the
inner molecular layer was more pronounced in animals
from the KA-DMSO and KA-HERB groups.
Discussion
In the present study, the tyrosine protein kinase inhibi-
tors, herbimycin A and K252a, modified the electrographic
epileptiform activity induced by intrahippocampal KA ad-
ministration but did not alter the cell loss pattern. K252a,
but not herbimycin, treatment reduced supragranular MFS.
Secretion of neurotrophins in the hippocampus, where
nerve growth factor (NGF) and BDNF are expressed abun-
dantly (15), is modulated significantly by neuronal activity
(6,16). Accordingly, the excitotoxin kainate induces neuro-
trophins NGF and BDNF mRNA synthesis in the hippo-
campus (17) and increases their protein content, although
408
Braz J Med Biol Res 41(5) 2008
C.M. Queiroz and L.E. Mello
www.bjournal.com.br
it is still not known if this effect is related to the compound
itself or to the KA-induced epileptiform activity. Intrahippo-
campal kainate administration leads to neuronal depolar-
ization that, in turn, releases neurotrophins that will further
depolarize neurons creating an excitatory feedback loop
that may eventually lead to hyperexcitation. In fact, intra-
hippocampal application of BDNF elicits electrographic
discharges with subsequent spontaneous seizures (18)
and it can exacerbate an ongoing status epilepticus (19).
Since secreted neurotrophins can powerfully stimulate
protein tyrosine kinase receptors leading to phosphoryla-
tion of tyrosine residues (20), we speculate that K252a and
herbimycin attenuate the electrographic seizures by de-
creasing tyrosine phosphorylation signaling. Our data sup-
port the role of protein tyrosine phosphorylation in the
acute seizure activity triggered by KA administration.
Both protein tyrosine kinase inhibitors used in the pres-
ent study were able to modify kainate-induced epileptiform
activity. While herbimycin inhibited the spreading of the
epileptiform activity to the contralateral hippocampus,
K252a reduced intermittent burst activity. The differences
between the inhibitors may be explained by their specificity
to the wide variety of tyrosine substrates. In fact, herbimy-
cin is described as having a broad spectrum of affinity for
tyrosine substrates, including strong inhibitory activity on
the family of the Src kinases (21). Src kinases have been
described as “a hub for NMDA receptor regulation” (22)
and have been involved in NMDA receptor phosphoryla-
tion during status epilepticus (23). On the other hand, bath
application of K252a inhibits BDNF-induced inhibition of
GABA-A receptor-mediated inhibitory postsynaptic cur-
rents in CA1 slices (24). By altering the balance between
excitatory and inhibitory synaptic transmissions in kainate-
induced epileptiform activity in the hippocampus, K252a
could change the pattern of epileptiform burst activity
(Figure 1). Independent of the mechanisms involved, the
present results suggest that herbimycin is a more powerful
inhibitor of kainate-induced epileptiform activity than K252a.
In contrast to previous results (25), K252a treatment
did not prevent seizure-induced cell death. This difference
may be explained by the administration routes used for KA
injection (systemic vs intrahippocampal) and K252a treat-
ment protocol (single icv acute injection vs 4 days of
systemic injection). In the same study, the authors also did
not find any EEG alterations in K252a-treated animals,
probably because the last K252a injection occurred 1
week before the KA administration. In that case, long-term
(4 days) pretreatment with K252a produced a neuroprotec-
tion independent of the KA-induced neuronal synchroniza-
tion (25). In the present study, we observed the opposite
effect, that is, attenuation of the KA-induced epileptiform
activity without preventing limbic cell death. These results
are consistent with the idea that K252a reduces neurotro-
phin-mediated neuronal excitation (20). Thus, despite re-
ducing neuronal excitation, protein tyrosine kinase inhibi-
tors were not able to prevent cell death and granule cell
dispersion. The intrahippocampal administration of KA
produced mild granular cell dispersion in the dentate gyrus
(Figure 4) and the inhibitors did not attenuate this altera-
tion. Recently, K252a was shown to retard granule cell
dispersion in mice treated with KA (10), although granule
cell dispersion was 300% higher than in controls (typical of
mice). In our study, this dispersion was in the order of 20%,
as described earlier for rats (26). These results suggest
that K252a and probably herbimycin acutely affect cellular
activation measured by EEG recordings but this effect is
not sufficient to prevent morphological alterations.
Our results showed that K252a reduces aberrant MFS
in KA-treated animals. However, herbimycin did not modify
aberrant MFS in KA-treated animals, which is curious
since this drug also inhibits protein tyrosine kinase and
attenuated epileptiform activity (Figure 1). There are two
possibilities to explain this effect. First, the inhibition of
epileptiform activity by K252a was more effective than
herbimycin in decreasing the levels of BDNF released
during status epilepticus (6). Since BDNF is one of the
major substances involved in fasciculation of mossy fibers,
K252a reduced aberrant MFS by decreasing its levels in
the hippocampus. A second possibility is that K252a has a
specific effect over MFS per se, i.e., the binding affinity and
drug kinetics make K252a a more suitable drug to inhibit
aberrant MFS. In fact, it was recently shown that K252a
disrupts mossy fiber pathfinding in organotypic culture of
hippocampal slices, probably by inhibiting the action of
endogenous neurotrophins and specifically the activation
of protein tyrosine kinase receptors (9,27). Similarly, we
have recently shown that herbimycin icv administration
failed to attenuate aberrant MFS in pilocarpine-induced
status epilepticus (13). It should be noted that the effect of
neurotrophins on MFS is still controversial (28), since there
are reports that show that MFS is not impaired in BDNF
knock-out animals (29) as well as the fact that no “sponta-
neous” (i.e., aberrant) MFS is observed in animals overex-
pressing BDNF (30). Our current data indicate that K252a,
but not herbimycin, influences KA-induced MFS and for
this reason we suggest that BDNF does have an important
role in the development of this plasticity.
Taken together, our results support the idea that neuro-
trophins can modify the epileptogenesis process (31,32)
and that this effect is mediated by protein tyrosine kinase
receptor signaling (33). Regarding the occurrence of spon-
taneous seizures as an indication of the epileptic condi-
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tion, in the present experiment only 2 animals of the 4 in the
KA-DMSO group presented spontaneous seizures, which
suggests a possible antiepileptogenic effect of herbimycin
and K252a. Herbimycin has been used unsuccessfully in
the pilocarpine-induced status epilepticus model, since
animals co-administered with herbimycin presented simi-
lar development of spontaneous seizure in the chronic
phase of the pilocarpine model of epilepsy (13). Given that
MFS was also reduced in the KA-K252a-treated animals,
future experiments with K252a in animal models with more
frequent seizures are encouraged.
Our current results indicate a crossroad where the use
of animal models with frequent seizures might have such
widespread cell damage that this cannot be counter-af-
fected by local (intraventricular) administration of protein
tyrosine kinase inhibitors. In contrast, the use of animal
models with more restricted damage, such as that used
here, may be more likely to be affected by local protein
tyrosine kinase inhibitor administration, but might require
an extensive investigation of spontaneous seizures given
their scarcity in these models. The importance of reaching
the basis for potential means to prevent epileptogenesis or
to modify disease progression certainly warrants the in-
vestment in these laborious studies.
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